Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Canada flag Canada · Delayed Price · Currency is CAD
0.700
+0.050 (7.69%)
Apr 28, 2026, 9:39 AM EST
55.56%
Market Cap 44.78M
Revenue (ttm) 719.58K
Net Income (ttm) -312.31K
Shares Out 68.89M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 6,198
Open 0.700
Previous Close 0.650
Day's Range 0.700 - 0.700
52-Week Range 0.295 - 1.100
Beta 0.15
RSI 45.79
Earnings Date Jun 26, 2026

About TSXV:EBM

Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for bones, teeth, and health; Eleotin G2000 for c... [Read more]

Founded 2010
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol EBM
Full Company Profile

Financial Performance

In fiscal year 2025, TSXV:EBM's revenue was 782,080, an increase of 11.40% compared to the previous year's 702,076. Losses were -332,767, -27.00% less than in 2024.

Financial Statements

News

There is no news available yet.